Genomenon, Inc. is a company offering innovative solutions in genomic data interpretation for clinical diagnostics and precision therapeutics. Their Mastermind Genomic Intelligence Platform uses AI to analyze and interpret vast datasets, offering insights into over 26 million variants and curated germline variant content. Genomenon provides software, data, and expert consulting services to support genomic research, drug development, and the commercialization of genomic therapies. They focus on accelerating NGS variant interpretation to enhance diagnostic yield and inform drug programs by connecting genomic variants to therapies and clinical trials.